Literature DB >> 18718514

Evaluation of generations 2, 3 and 4 arginine modified PAMAM dendrimers for gene delivery.

Hye Yeong Nam1, Hwa Jeong Hahn, Kihoon Nam, Woo-Hyung Choi, Yunseong Jeong, Dong-Eun Kim, Jong-Sang Park.   

Abstract

It is a matter of concern to develop and design synthetic non-viral gene carriers with high transfection efficiency and low cytotoxicity in gene therapy. Recently, various arginine conjugated dendrimers showed better performance in transfection and greater viability than polyethyleneimine (PEI). In this study, we synthesized and investigated e-PAM-R G2, 3 and 4 which are biodegradable polyamidoamine (PAMAM) dendrimers modified with arginine and compared that with PAMAM-R series containing amide bonds for gene carriers. For plasmid DNA delivery, the transfection efficiency of e-PAM-R G4 was higher than G3 and G2 and similar to PAMAM-R G4 with favorable cell viability. Moreover, they indicated significantly higher suppression of TEL/AML1 protein, maybe due to rapid olidonucleotide (ODNs) release through biodegradability of e-PAM-R. These results suggest that biodegradable and non-toxic e-PAM-R may be useful carriers for the gene including plasmid DNA, antisense ODNs and si-RNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718514     DOI: 10.1016/j.ijpharm.2008.07.021

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

1.  Enzyme-synthesized poly(amine-co-esters) as nonviral vectors for gene delivery.

Authors:  Jie Liu; Zhaozhong Jiang; Jiangbing Zhou; Shengmin Zhang; W Mark Saltzman
Journal:  J Biomed Mater Res A       Date:  2010-12-09       Impact factor: 4.396

Review 2.  Functional magnetic nanoparticles for non-viral gene delivery and MR imaging.

Authors:  Ruijun Xing; Gang Liu; Jinghan Zhu; Yanglong Hou; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

3.  Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium.

Authors:  Hye Y Nam; Arlo McGinn; Pyung-Hwan Kim; Sung W Kim; David A Bull
Journal:  Biomaterials       Date:  2010-07-31       Impact factor: 12.479

4.  Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency.

Authors:  Hui Wang; Hai-Bo Shi; Shan-Kai Yin
Journal:  Exp Ther Med       Date:  2011-06-27       Impact factor: 2.447

Review 5.  Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.

Authors:  Prashant Kesharwani; Arun K Iyer
Journal:  Drug Discov Today       Date:  2014-12-31       Impact factor: 7.851

6.  Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain.

Authors:  Il-Doo Kim; Joo-Hyun Shin; Seung-Woo Kim; Sunghyun Choi; Junseong Ahn; Pyung-Lim Han; Jong-Sang Park; Ja-Kyeong Lee
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

7.  Chemical nature and structure of organic coating of quantum dots is crucial for their application in imaging diagnostics.

Authors:  Rumiana Bakalova; Zhivko Zhelev; Daisuke Kokuryo; Lubomir Spasov; Ichio Aoki; Tsuneo Saga
Journal:  Int J Nanomedicine       Date:  2011-08-18

8.  Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic.

Authors:  Songhie An; Kihoon Nam; Sunghyun Choi; Cheng Z Bai; Yan Lee; Jong-Sang Park
Journal:  Int J Nanomedicine       Date:  2013-02-25

9.  Acetylation of PAMAM dendrimers for cellular delivery of siRNA.

Authors:  Carolyn L Waite; Sarah M Sparks; Kathryn E Uhrich; Charles M Roth
Journal:  BMC Biotechnol       Date:  2009-04-23       Impact factor: 2.563

10.  Biomimetics: From Bioinformatics to Rational Design of Dendrimers as Gene Carriers.

Authors:  Valeria Márquez-Miranda; María Belén Camarada; Ingrid Araya-Durán; Ignacio Varas-Concha; Daniel Eduardo Almonacid; Fernando Danilo González-Nilo
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.